181 related articles for article (PubMed ID: 3440638)
1. Comparison of the effect of aminoglycosides on excretion of N-acetyl-beta-glucosaminidase.
Fujita K; Murayama T; Kawamura M; Narita K
Int J Clin Pharmacol Res; 1987; 7(6):477-80. PubMed ID: 3440638
[TBL] [Abstract][Full Text] [Related]
2. [An early and specific indicator of aminoglycoside nephrotoxicity: isoenzyme B of urinary N-acetyl-beta-D-glucosaminidase (NAG)].
Gibey R; Dupond JL; Peltier H; Iehl-Robert M; Henry JC
Pathol Biol (Paris); 1986 May; 34(5):342-5. PubMed ID: 3534703
[TBL] [Abstract][Full Text] [Related]
3. [Isoenzymes of N-acetyl-beta-D-glucosaminidase (NAG): new method of evaluating the nephrotoxicity of aminosides. Our experience with dibekacin in geriatrics].
Gibey R; Dupond JL; Mallet H; Guerber F; Iehl-Robert M; Flausse-Parrot F; Becker M
Nephrologie; 1986; 7(2):51-5. PubMed ID: 3736764
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent aminoglycoside nephrotoxicity.
Fujita K; Sayama T; Abe S; Murayama T; Tashiro H
J Urol; 1985 Sep; 134(3):596-7. PubMed ID: 4032563
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of gentamicin, amikacin and dactimicin on excretion of N-acetyl-beta-D-glucosaminidase (NAG) and kidney histological pattern in rats.
Palla R; Paternoster G; Galigani P; Giovannini L; Bertelli AA; Romano MR; Alessandrì MG; Bertelli A
Drugs Exp Clin Res; 1987; 13(12):751-6. PubMed ID: 3447879
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
Naruse T; Hirokawa N; Oike S; Maekawa T
Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):313-29. PubMed ID: 7221185
[TBL] [Abstract][Full Text] [Related]
7. [Influence of aminoglycosides on the activity of urinary N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzymes].
Mozer JL; Gibey R; Dupond JL; Henry JC
Pathol Biol (Paris); 1988 Mar; 36(3):230-4. PubMed ID: 3283685
[TBL] [Abstract][Full Text] [Related]
8. Urinary N-acetyl-beta-D-glucosaminidase (NAG) in aminoglycoside nephrotoxicity.
Assadamongkol K; Tapaneya-Olarn W; Chatasingh S
J Med Assoc Thai; 1989 Jan; 72 Suppl 1():42-6. PubMed ID: 2732646
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of urinary elimination of N-acetyl-beta-glucosaminidase in healthy volunteers treated with dibekacin or gentamicin.
Camí J; Segura J; Baños JE; Garcia I; Drobnic L
Antimicrob Agents Chemother; 1982 Jun; 21(6):1013-5. PubMed ID: 7114833
[TBL] [Abstract][Full Text] [Related]
10. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 10. Clinical significance of urinary NAG activity in patients with kidney diseases, with special reference to nephrotic syndrome and antibiotic treatment].
Ishimoto F; Shibazaki T; Murai S; Kodama K; Ohno I; Gomi H
Rinsho Byori; 1983 Sep; Spec No 56():147-59. PubMed ID: 6663756
[No Abstract] [Full Text] [Related]
11. The predictive value of urinary N-acetyl-beta-D-glucosaminidase in evaluating aminoglycoside nephrotoxicity.
Guh JY; Su YH; Chen HJ; Tsai JH
Taiwan Yi Xue Hui Za Zhi; 1985 Oct; 84(10):1099-107. PubMed ID: 3866825
[No Abstract] [Full Text] [Related]
12. [Determination of urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion as a parameter of nephrotoxicity due to cis-platin and the effect of fosfomycin (FOM) on its nephrotoxicity].
Matsuoka R; Inoue T; Miyamura K; Mizutani K; Koike S; Mori H; Kigawa T
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2037-44. PubMed ID: 3794453
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of urinary n-acetyl-beta-d-glucosaminidase activity in patients treated with aminoglycosides].
Hirokawa N; Naruse T
Nihon Jinzo Gakkai Shi; 1982 Sep; 24(9):1041-53. PubMed ID: 7161951
[No Abstract] [Full Text] [Related]
14. Urinary excretion of beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase in advanced neuroblastoma patients receiving cis-diamminedichloroplatinum(II).
Ikeda H; Nagashima K; Okumura H; Takahashi A; Matsuyama S; Nagamachi Y
Eur J Surg Oncol; 1988 Feb; 14(1):17-20. PubMed ID: 3278937
[TBL] [Abstract][Full Text] [Related]
15. Comparative nephrotoxicity of dibekacin and gentamicin in rats.
Elliott WC; Parker RA; Houghton DC; Gilbert DN; Bennett WM
Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):419-32. PubMed ID: 7330450
[TBL] [Abstract][Full Text] [Related]
16. Nephrotoxicity of dactimicin, a novel pseudo-disaccharide aminoglycoside possessing the N-formimidoyl group, compared with that of astromicin, amikacin and other aminoglycoside antibiotics in animals.
Inouye S; Niizato T; Shomura T; Kitasato I
Drugs Exp Clin Res; 1989; 15(5):189-209. PubMed ID: 2791871
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of urinary N-acetyl-beta-D-glucosaminidase activities in surgery].
Kamioka T
Nihon Geka Gakkai Zasshi; 1985 Jun; 86(6):657-68. PubMed ID: 4033621
[TBL] [Abstract][Full Text] [Related]
18. [Effects of intravenous urography using sodium and meglumine ioxitalamate (Telebrix 38) on blood creatinine and urinary excretion of N-acetyl-beta-D-glucosaminidase].
Lacour B; Lacroix C; Jungers P; Bailly M
Ann Biol Clin (Paris); 1984; 42(6):407-11. PubMed ID: 6532266
[TBL] [Abstract][Full Text] [Related]
19. Proximal tubule damage in patients treated with gentamicin or amikacin.
Wiland P; Szechciński J
Pol J Pharmacol; 2003; 55(4):631-7. PubMed ID: 14581723
[TBL] [Abstract][Full Text] [Related]
20. N-acetyl-beta-glucosaminidase in the localization of the site of urinary tract infections.
Chan MK
Singapore Med J; 1990 Apr; 31(2):135-7. PubMed ID: 2371577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
